Disc Medicine CEO exercises options for 36K shares
Disc Medicine’s CEO exercised fully vested stock options for 36,000 shares, increasing his direct common share holdings to 262,064.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Disc Medicine, Inc. (IRON) reports that Chief Executive Officer and director John D. Quisel exercised options for 36,000 shares of common stock on September 15, 2026 at an exercise price of $1.01 per share. The underlying options were fully vested and exercisable, and he now directly holds 262,064 common shares and 150,120 option shares. No Rule 10b5-1 trading plan is reported for these transactions.
Insider Trade Summary
36,000 shares exercised/converted
Exercise
2 txns
Insider
Quisel John D
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 36,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 36,000 | $1.01 | $36K |
Holdings After Transaction:
Stock Option (Right to Buy) — 150,120 contracts (Direct);
Common Stock — 262,064 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 186,120 to 150,120 contracts (Direct);
Common Stock, 226,064 to 262,064 shares (Direct)
Footnotes (1)
- F1. The shares underlying this option are fully vested and exercisable as of the date hereof.
Key Figures
Options exercised: 36,000 shares
Exercise price: $1.01 per share
Common shares held after transaction: 262,064 shares
+3 more
6 metrics
Options exercised
36,000 shares
Stock options converted into common stock on September 15, 2026
Exercise price
$1.01 per share
Price paid to exercise 36,000 stock options into common stock
Common shares held after transaction
262,064 shares
Direct common stock ownership by CEO John D. Quisel after the exercise
Remaining option shares
150,120 shares
Option position reported following the option exercise
Option expiration date
March 10, 2030
Expiration for the option grant from which 36,000 shares were exercised
Transaction date
September 15, 2026
Date of the option exercise and resulting acquisition of common stock
Key Terms
stock option, common stock, exercise price
3 terms
stock option financial
"The filing reports the exercise of a stock option for 36,000 shares."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
common stock financial
"The options were exercised into shares of common stock held directly."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"The exercise price for the option was $1.01 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Disc Medicine (IRON) disclose about its CEO’s recent equity transaction?
Disc Medicine disclosed that CEO John D. Quisel exercised options for 36,000 shares of common stock on September 15, 2026 at an exercise price of $1.01 per share, increasing his direct common share holdings to 262,064 shares.
What type of transaction did the Disc Medicine (IRON) CEO report on September 15, 2026?
On September 15, 2026, CEO John D. Quisel reported an option exercise, converting 36,000 option shares into 36,000 shares of common stock at an exercise price of $1.01 per share.
Were the Disc Medicine (IRON) CEO’s options fully vested at the time of exercise?
Yes. A footnote states that the 36,000 option shares exercised by CEO John D. Quisel were fully vested and exercisable as of the transaction date.
Was a Rule 10b5-1 trading plan used for the Disc Medicine (IRON) CEO’s transaction?
No. The filing indicates that no Rule 10b5-1 trading plan was reported in connection with CEO John D. Quisel’s option exercise and related share acquisition.
What is the remaining option position of the Disc Medicine (IRON) CEO after this exercise?
After exercising options for 36,000 shares, CEO John D. Quisel has 150,120 shares remaining under stock options, with those options scheduled to expire on March 10, 2030.
AI-generated analysis. How Rhea-AI works. Not financial advice.
